(Korean) 보로노이, 美 피라미드에 1조원 규모 고형암 치료제 기술수출 – 이데일리

2021-11-24T16:31:53+00:00

Sorry, this entry is only available in Korean.

(Korean) 보로노이, 美 피라미드에 1조원 규모 고형암 치료제 기술수출 – 이데일리2021-11-24T16:31:53+00:00

(Korean) 보로노이, 자가면역질환 치료제 3,750억원 규모 기술수출 – 매일경제

2021-11-09T10:17:26+00:00

Sorry, this entry is only available in Korean.

(Korean) 보로노이, 자가면역질환 치료제 3,750억원 규모 기술수출 – 매일경제2021-11-09T10:17:26+00:00

(Korean) 이노엔, 보로노이서 ‘선택적 RET 저해제’ 도입…항암신약 개발 – 한국경제 BIO Insight

2021-11-09T10:17:05+00:00

Sorry, this entry is only available in Korean.

(Korean) 이노엔, 보로노이서 ‘선택적 RET 저해제’ 도입…항암신약 개발 – 한국경제 BIO Insight2021-11-09T10:17:05+00:00

JW Pharmaceutical·VORONOI, Joint develpoment of targeting STAT3 in anticancer field

2021-11-09T10:00:40+00:00

JW Pharmaceutical·VORONOI, Joint develpoment of targeting STAT3 in anticancer field - mk.co.kr On December 2, JW Pharmaceutical inked a deal with Korean biotech startup Voronoi to develop next-generation innovative new drugs. It plans to develop a next-generation innovative new drug with global competitiveness by combining JW Pharmaceutical's small molecule anticancer drug candidate of targeting STAT3 with Voronoi's protein decomposition technology 'Protein Degrader(PROTAC; Proteolysis-targeting chimera)'. 기사 전문보기

JW Pharmaceutical·VORONOI, Joint develpoment of targeting STAT3 in anticancer field2021-11-09T10:00:40+00:00

Dana-Farber Cancer Institute visits VORONOI…”Strengthening partnerships by strengthening joint research, etc.”

2021-11-09T10:19:19+00:00

Sorry, this entry is only available in Korean.

Dana-Farber Cancer Institute visits VORONOI…”Strengthening partnerships by strengthening joint research, etc.”2021-11-09T10:19:19+00:00

Dana-Farber Cancer Institute grants exclusive right of protein degradation patent to Voronoi – Asia Biz

2019-12-30T18:22:31+00:00

Dana-Farber Cancer Institute grants exclusive right of protein degradation patent to Voronoi-AsiaBiz View the update

Dana-Farber Cancer Institute grants exclusive right of protein degradation patent to Voronoi – Asia Biz2019-12-30T18:22:31+00:00

Nathanael Gray and Eric Fischer along with Deerfield Management create new Center for Protein Degradation at DFCI

2019-07-04T18:21:55+00:00

Dana-Farber Cancer Institute and Deerfield Management announced today an up to $80 million collaboration to create the Center for Protein Degradation at Dana-Farber to be led by BCMP Faculty members, Nathanael Gray and Eric Fischer,.

Nathanael Gray and Eric Fischer along with Deerfield Management create new Center for Protein Degradation at DFCI2019-07-04T18:21:55+00:00

Voronoi’s NSCLC program gains lots of excitement from AACR

2021-01-27T09:21:53+00:00

미국 암학회 대표, 한국 벤처 극찬..폐암 치료제 호평 - 헤럴드경제 암학회(AACR) 대표 마가렛 포티 박사 트위터로 한국기업 보로노이 발표 올리며 "큰 관심 쏟아져" "복수의 글로벌사와 기술수출 협의 중" 대박 기대감 기사 전문보기

Voronoi’s NSCLC program gains lots of excitement from AACR2021-01-27T09:21:53+00:00